Rhythm Pharmaceuticals officer proposes $407K share sale
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
144
Rhea-AI Filing Summary
Rhythm Pharmaceuticals, Inc. (RYTM) officer Pamela Cramer reported a proposed sale of 3,520 common shares, with an aggregate market value of $407,017.60 and an approximate sale date of August 10, 2026. Morgan Stanley Smith Barney LLC is named as the broker.
Key Figures
Shares proposed for sale: 3,520 common shares
Aggregate market value: $407,017.60
Date acquired: August 10, 2026
+1 more
4 metrics
Shares proposed for sale
3,520 common shares
Approximate sale date: August 10, 2026
Aggregate market value
$407,017.60
Shares proposed for sale
Date acquired
August 10, 2026
Acquired through exercise of stock options
Plan adoption or instruction date
December 15, 2025
Date listed for Rule 10b5-1 reliance
Key Terms
Aggregate Market Value, Exercise of Stock Options, Rule 10b5-1
3 terms
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Exercise of Stock Options financial
"Nature of Acquisition Transaction: Exercise of Stock Options"
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.